Alexander Fowkes
Keine laufenden Positionen mehr
Profil
Alexander Fowkes worked as an Executive Director-Asia R&D at Pfizer Inc. from 2006 to 2011.
He then worked as a Senior Vice President & Head-Commercial Operations at both Wuxi PharmaTech (Cayman), Inc. and WuXi AppTec Co., Ltd.
Mr. Fowkes received his undergraduate degree from The University of Queensland and his graduate degree from Bond University.
Ehemalige bekannte Positionen von Alexander Fowkes
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2011 |
| WUXI PHARMATECH (CAYMAN) INC. (ADR) | Corporate Officer/Principal | - |
| WUXI APPTEC CO., LTD. | Corporate Officer/Principal | - |
Ausbildung von Alexander Fowkes
| The University of Queensland | Undergraduate Degree |
| Bond University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| WUXI APPTEC CO., LTD. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Wuxi PharmaTech (Cayman), Inc.
 Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China. | Health Technology |
